Start the conversation
Best stocks to buy roundup, week ending Oct. 3, 2014:October arrived last week as we pulled together the best stocks to give Money Morning readers a portfolio boost in the last quarter of 2014. Each investment was recently handpicked by our experts – and they all hail from the tech sector.
Our bioscience investment specialist recommended readers jump on shares of a pharmaceutical company. After a 780% run over the last two years, its shares recently plunged after a false media report came out in early September. Investors can nab shares now at a deep discount.
Meanwhile, our defense & tech specialist highlighted an ETF that lets investors play ten of the top tech stocks today that have undergone CEO changes in the last three years – a move that typically unleashes a company's share price. He also identified two big cap tech stocks to buy based on his proven method of technical analysis.
You can find all of last week's tips and recommendations here in our latest list of the best stocks to buy now.
Money Morning's Latest "Best Stocks to Buy" List
- Money Morning BioScience Investment Specialist Ernie Tremblay alerted readers to "an extraordinary (maybe once in a lifetime) opportunity" to get in on a biotech stock at a deep discount. The company, which makes pharmaceutical products for patients with renal disease, has had a great run over the two years ending Aug. 29 – investors raked in a whopping 780% profit over their original position. But in September, a media blunder caused the stock to fall more than 11% over just a few days. That means investors can snap up the stock on the cheap right now, and enjoy gains as it rebounds and continues on an impressive run that Tremblay predicts will last over the next couple of years…
- Over the past three years, no fewer than 10 of the top tech companies in Silicon Valley have installed new CEOs – and the moves have given a boost to each respective stock. "The arrival of a new CEO can serve as an explosive catalyst for a stock's share price," Money Morning Defense & Tech Specialist Michael A. Robinson said last week. Robinson pointed out a way to invest in these CEOs' success all at once, for a price well below what many of these top tech firms' stocks cost. It's an ETF that has already outpaced the overall market by 46.5% so far this year and, even better, it's "a great foundational investment you can hold for the long haul"…